Johnson & Johnson (JNJ)
158.24
-1.89
(-1.18%)
USD |
NYSE |
Nov 04, 16:00
158.05
-0.19
(-0.12%)
Pre-Market: 08:32
Johnson & Johnson Cash from Financing (Quarterly): -9.882B for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -9.882B |
| June 30, 2024 | 7.544B |
| March 31, 2024 | 546.00M |
| December 31, 2023 | -4.655B |
| September 30, 2023 | -11.32B |
| June 30, 2023 | -5.991B |
| March 31, 2023 | 6.138B |
| December 31, 2022 | 1.70B |
| September 30, 2022 | -3.925B |
| June 30, 2022 | -2.261B |
| March 31, 2022 | -4.385B |
| December 31, 2021 | -3.436B |
| September 30, 2021 | -2.207B |
| June 30, 2021 | -3.279B |
| March 31, 2021 | -5.125B |
| December 31, 2020 | -5.644B |
| September 30, 2020 | 4.196B |
| June 30, 2020 | -357.00M |
| March 31, 2020 | -4.315B |
| December 31, 2019 | -4.072B |
| September 30, 2019 | -3.893B |
| June 30, 2019 | -4.534B |
| March 31, 2019 | -5.516B |
| December 31, 2018 | -6.389B |
| September 30, 2018 | -3.477B |
| Date | Value |
|---|---|
| June 30, 2018 | -2.674B |
| March 31, 2018 | -5.97B |
| December 31, 2017 | -3.537B |
| September 30, 2017 | -2.069B |
| June 30, 2017 | -1.917B |
| March 31, 2017 | -150.00M |
| December 31, 2016 | -3.464B |
| September 30, 2016 | -3.445B |
| June 30, 2016 | -1.038B |
| March 31, 2016 | -604.00M |
| December 31, 2015 | -3.294B |
| September 30, 2015 | -1.84B |
| June 30, 2015 | -2.775B |
| March 31, 2015 | -3.227B |
| December 31, 2014 | -858.00M |
| September 30, 2014 | -5.716B |
| June 30, 2014 | -2.868B |
| March 31, 2014 | -3.057B |
| December 31, 2013 | 1.182B |
| September 30, 2013 | -4.519B |
| June 30, 2013 | -1.977B |
| March 31, 2013 | -777.00M |
| December 31, 2012 | -1.471B |
| September 30, 2012 | -1.653B |
| June 30, 2012 | -16.26B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-11.32B
Minimum
Sep 2023
7.544B
Maximum
Jun 2024
-2.536B
Average
-3.680B
Median
Cash from Financing (Quarterly) Benchmarks
| Amgen Inc | -3.651B |
| Eli Lilly and Co | 211.30M |
| Merck & Co Inc | 1.216B |
| Pfizer Inc | -2.459B |
| AbbVie Inc | -3.072B |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.993B |
| Cash from Investing (Quarterly) | -3.128B |
| Free Cash Flow | 19.02B |
| Free Cash Flow Per Share (Quarterly) | 2.354 |
| Free Cash Flow to Equity (Quarterly) | 11.45B |
| Free Cash Flow to Firm (Quarterly) | 5.714B |
| Free Cash Flow Yield | 4.95% |